Pharma Mar SA
OTC:PHMMF

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
OTC:PHMMF
Watchlist
Price: 31.15 USD Market Closed
Updated: May 27, 2024

Pharma Mar SA
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Mar SA
Net Income (Common) Peer Comparison

Comparables:
GRF
ORY
BST

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Mar SA
MAD:PHM
Net Income (Common)
€2m
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Grifols SA
MAD:GRF
Net Income (Common)
€59.3m
CAGR 3-Years
-54%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Net Income (Common)
-€3.4m
CAGR 3-Years
0%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Biotechnology Assets SA
MAD:BST
Net Income (Common)
€1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharma Mar SA's Net Income (Common)?
Net Income (Common)
2m EUR

Based on the financial report for Mar 31, 2024, Pharma Mar SA's Net Income (Common) amounts to 2m EUR.

What is Pharma Mar SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-17%

Over the last year, the Net Income (Common) growth was -93%. The average annual Net Income (Common) growth rates for Pharma Mar SA have been -72% over the past three years , and -17% over the past ten years .